Aristotle University of Thessaloniki, Hippokratio Hospital, Hellas, Greece.
Surg Infect (Larchmt). 2010 Dec;11(6):535-44. doi: 10.1089/sur.2009.069.
We created a questionnaire with the aim of evaluating surgeon compliance with the guidelines for antibiotic use in the perioperative period in intra-abdominal surgical infections. We discuss the problems emerging from non-adherence to these guidelines.
In the questionnaire, we tried to correlate the type of intra-abdominal infection with: (1) Time of antibiotic administration commencement; (2) type of antibiotic(s) administered; (c) duration of antibiotic administration; and (4) modification of antibiotic type/duration of administration in the presence of factors increasing the risk of treatment failure. In order to collect and process the data more easily, the patients were divided into four groups-Group A: Community patients with intra-abdominal surgical infections and simple contamination of the peritoneal cavity according to the Surgical Infection Society (SIS) guidelines; Group B: Community patients with an intra-abdominal surgical infection evolving to secondary peritonitis per SIS guidelines; Group C: Community patients with an intra-abdominal surgical infection with a high risk of surgical site infection; and Group D: Patients with recent hospitalization or nosocomial or postoperative intra-abdominal infection.
The questionnaire was sent to the directors of 43 surgical clinics in northern Greece, and 27 answered (63%). In 81.5% of the clinics (median 22; range 15-24), depending on the type of infection, empirical antibiotic treatment commenced preoperatively. In Group A, on average, 29.6% of the clinics (median 8; range 5-16) administer antibiotics for as long as 24 h, and 11.1% (median 3; range 1-10) use antibiotics not recommended in the SIS guidelines (e.g., third- and fourth-generation cephalosporins, ciprofloxacin, imipenem-cilastatin, meropenem, or piperacillin/tazobactam). In Group B, 22.2% of clinics (median 6; range 2-15) administer antibiotics for three to five days, and 14.8% (median 4; range 1-11) use antibiotics outside SIS guidelines. In Group C, 40.7% of clinics (median 11; range 1-14) administer antibiotics for more than five days, and 14.8% (median 4; range 1-14) use antibiotics that are outside the SIS guidelines. In Group D, 11.1% of clinics (median 3; range 2-5) do not cover Enterococcus with the antibiotics administered.
There seems to be confusion in determining the situations with simple contamination of the peritoneal cavity, whose treatment requires short-duration antibiotic administration, and in the type of antibiotics administered to various patient groups, elements that lead to prolonged or erroneous administration of antibiotic drugs. Continuous discussion and surgeon training is imperative and may be the best choice to ensure familiarity with antibiotics and their proper use and thus to minimize serious adverse events and treatment failure.
我们创建了一个问卷,旨在评估外科医生在腹腔内手术感染的围手术期抗生素使用指南方面的依从性。我们讨论了不遵守这些指南所带来的问题。
在问卷中,我们尝试将腹腔内感染的类型与以下因素相关联:(1)抗生素使用开始时间;(2)使用的抗生素类型;(3)抗生素使用持续时间;以及(4)在增加治疗失败风险的因素存在时,抗生素类型/使用时间的修改。为了更方便地收集和处理数据,将患者分为四组:A 组:根据外科感染学会(SIS)指南,社区中患有腹腔内手术感染和简单腹腔污染的患者;B 组:根据 SIS 指南,社区中患有进展为继发性腹膜炎的腹腔内手术感染的患者;C 组:社区中患有高手术部位感染风险的腹腔内手术感染患者;以及 D 组:近期住院或院内或术后腹腔内感染的患者。
问卷发送给了希腊北部 43 家外科诊所的主任,其中 27 家(63%)做出了回应。在 81.5%的诊所(中位数 22;范围 15-24)中,根据感染类型,术前开始经验性抗生素治疗。在 A 组中,平均有 29.6%的诊所(中位数 8;范围 5-16)使用抗生素的时间长达 24 小时,有 11.1%的诊所(中位数 3;范围 1-10)使用 SIS 指南不推荐的抗生素(例如,第三代和第四代头孢菌素、环丙沙星、亚胺培南-西司他丁、美罗培南或哌拉西林/他唑巴坦)。在 B 组中,有 22.2%的诊所(中位数 6;范围 2-15)使用抗生素 3-5 天,有 14.8%的诊所(中位数 4;范围 1-11)使用 SIS 指南之外的抗生素。在 C 组中,有 40.7%的诊所(中位数 11;范围 1-14)使用抗生素超过 5 天,有 14.8%的诊所(中位数 4;范围 1-14)使用 SIS 指南之外的抗生素。在 D 组中,有 11.1%的诊所(中位数 3;范围 2-5)未用抗生素覆盖肠球菌。
在确定单纯腹腔污染的情况以及各种患者群体使用的抗生素类型方面似乎存在混淆,这导致了抗生素的延长或错误使用。持续的讨论和外科医生培训是必要的,这可能是确保熟悉抗生素及其正确使用的最佳选择,从而最大限度地减少严重不良事件和治疗失败的发生。